2m 2m 2m 2m 2m 2m 2m
AVANOS MEDICAL (AVNS)
NYSE
$24.93$0.00 (0.00%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.2BMarket Cap
- 105.62%1-Year Change
- Medical DevicesIndustry
AVANOS MEDICAL (AVNS)
$24.93$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 673.3M -17.89% | 820.0M +10.13% | |
Cost of Revenue | 347.3M +13.31% | 306.5M +4.39% | 293.6M -20.65% | 370.0M -2.71% | |
Gross Profit | 353.9M -7.19% | 381.3M +0.42% | 379.7M -15.62% | 450.0M +23.52% | |
Sales and Marketing Expense | 315.6M -0.91% | 318.5M -4.93% | 335.0M -2.02% | 341.9M +13.85% | |
Research and Development Expense | -1.6M -97.58% | -66.0M +142.65% | -27.2M -11.11% | -30.6M -5.26% | |
Depreciation and Amortization Expense | 38.9M -14.51% | 45.5M -1.30% | 46.1M -3.35% | 47.7M +24.54% | |
Total Operating Expenses | 347.3M +13.31% | 306.5M +4.39% | 293.6M -20.65% | 370.0M -2.71% | |
Operating Profit | -72.9M -81.41% | -392.1M -9,435.71% | 4.2M -94.32% | 74.0M +731.46% | |
Interest Income | 3.2M -37.25% | 5.1M +75.86% | 2.9M +141.67% | 1.2M +500.00% | |
Interest Expense | N/A N/A | N/A N/A | -15.0M +50.00% | -10.0M +203.03% | |
Interest Income and Expense and Net | 3.2M -37.25% | 5.1M +142.15% | -12.1M +37.50% | -8.8M +183.87% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 15.0M +50.00% | 10.0M +203.03% | |
Income before Taxes | -72.9M -81.41% | -392.1M +4,863.29% | -7.9M -112.12% | 65.2M +1,024.14% | |
Income Taxes | 6.7M +139.41% | -17.0M -950.00% | 2.0M -86.39% | 14.7M +2,350.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -72.9M -81.41% | -392.1M +534.47% | -61.8M -222.38% | 50.5M +871.15% | |
Net Income from Continuing Operations Applicable to Common | -72.9M -81.41% | -392.1M +3,860.61% | -9.9M -115.18% | 65.2M +1,024.14% | |
Basic EPS and Net Income | -1.57 -81.59% | -8.53 +546.21% | -1.32 -222.22% | 1.08 +881.82% | |
Diluted EPS and Net Income | -1.57 -81.59% | -8.53 +546.21% | -1.32 -223.36% | 1.07 +872.73% | |
Basic Weighted Average Shares | 46.3M +0.65% | 46.0M -1.29% | 46.6M -0.64% | 46.9M -2.49% | |
Diluted Weighted Average Shares | 46.3M +0.65% | 46.0M -1.29% | 46.6M -1.48% | 47.3M -2.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 89.8M -16.62% | 107.7M +22.81% | 87.7M -31.32% | 127.7M +7.76% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 89.8M -16.62% | 107.7M +22.81% | 87.7M -31.32% | 127.7M +7.76% | |
Total Current Assets | 355.4M -9.66% | 393.4M -19.22% | 487.0M -2.56% | 499.8M +19.40% | |
Accumulated Depreciation | 152.1M +9.66% | 138.7M +12.86% | 122.9M -20.71% | 155.0M +13.80% | |
Property and Plant and Equipment and Net | 113.4M +2.44% | 110.7M -5.55% | 117.2M -28.49% | 163.9M -2.50% | |
Total Long-Term Assets | 31.5M +35.78% | 23.2M +20.21% | 19.3M +9.66% | 17.6M +6.67% | |
Total Assets | 1.1B -6.97% | 1.2B -31.80% | 1.7B -5.29% | 1.8B +12.06% | |
Income Taxes Payable | 6.1M +10.91% | 5.5M -76.89% | 23.8M -6.30% | 25.4M +164.58% | |
Total Short-Term Debt | 10.2M +8.51% | 9.4M +9.30% | 8.6M +38.71% | 6.2M -95.23% | |
Total Current Liabilities | 165.2M -0.42% | 165.9M -29.28% | 234.6M +26.26% | 185.8M +33.48% | |
Total Long-Term Debt | 90.3M -27.93% | 125.3M -21.39% | 159.4M -29.56% | 226.3M +74.08% | |
Total Long-Term Liabilities | 13.5M +206.82% | 4.4M -56.00% | 10.0M -57.45% | 23.5M +158.24% | |
Total Liabilities | 295.5M -9.27% | 325.7M -28.59% | 456.1M -7.99% | 495.7M +49.89% | |
Retained Earnings | -779.9M +10.31% | -707.0M +124.52% | -314.9M +24.42% | -253.1M -18.43% | |
Total Stockholders Equity | 778.2M -6.07% | 828.5M -32.99% | 1.2B -4.25% | 1.3B +2.16% | |
Total Shares Outstanding | 46.5M +1.07% | 46.0M -0.46% | 46.2M -0.76% | 46.5M -3.48% | |
Cash Flow | |||||
Cash from Operating Activities | 74.7M -25.82% | 100.7M +210.80% | 32.4M -64.36% | 90.9M +4.12% | |
Capital Expenditures | 31.6M +77.53% | 17.8M 0.00% | 17.8M -7.77% | 19.3M -8.10% | |
Cash from Investing Activities | -60.6M +120.36% | -27.5M -227.31% | 21.6M +115.95% | -135.4M +544.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -37.0M -24.64% | -49.1M -47.88% | -94.2M -266.14% | 56.7M +202.53% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 56.39% +2.76% | 54.88% +12.17% | |
Operating Margin | N/A N/A | N/A N/A | 0.62% -93.09% | 9.02% +654.99% | |
Return on Assets | -6.54% -76.24% | -27.55% +675.50% | -3.55% -218.94% | 2.99% +838.36% | |
Return on Equity | -9.07% -76.11% | -37.98% +676.65% | -4.89% -223.71% | 3.95% +858.05% | |
Revenue Growth | N/A N/A | N/A N/A | -17.89% -276.67% | 10.13% +142.89% | |
Current Ratio | 2.15 -9.28% | 2.37 +14.23% | 2.08 -22.83% | 2.69 -10.55% | |
Cash Ratio | 0.54 -16.27% | 0.65 +73.68% | 0.37 -45.61% | 0.69 -19.26% | |
Debt-to-Equity Ratio | 0.13 -20.60% | 0.16 +19.65% | 0.14 -24.54% | 0.18 -12.45% | |
Debt-to-Assets Ratio | 0.09 -19.79% | 0.12 +17.52% | 0.10 -23.67% | 0.13 -20.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow